Radiation therapy and immune function in young women with breast cancer
Part of Cancer, Skin clinical trials.
This trial looks at how radiation therapy affects the thymus, a gland that helps your immune system. If you are a young woman having surgery for breast cancer, you may be able to join and help researchers learn more about preserving immune health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 50
- You are having a mastectomy or lumpectomy for breast cancer
- You have not had radiation to your chest before for another cancer
- You have not had your thymus gland removed or taken immune-suppressing drugs in the last six months
- You do not have rheumatoid arthritis or other autoimmune diseases
- You do not have Down syndrome
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system changes in people with breast cancer, using patient tissue samples. It may help researchers understand immune responses in young women and guide future cancer treatments.
This trial uses individual measures of how sensitive your body’s tissues are to radiation to guide after-surgery breast radiation treatment. It aims to keep treatment safe and effective while tailoring the plan to each person.
This study looks at how your immune system changes while you receive standard breast cancer treatments. The researchers measure immune-related signals during your treatment to better understand what may be happening in triple-negative or certain hormone-receptor breast cancers.
This trial tests a shorter, more intense course of radiation to the whole breast after chemotherapy in women age 60 or older with early-stage breast cancer. It is designed for those who had a lumpectomy and are at higher risk based on genetic tests like Mammaprint or Oncotype.
This trial studies whether some patients with early-stage breast cancer can safely skip a specific part of radiation to the inner chest (called internal mammary irradiation). It may reduce radiation side effects while still aiming to prevent the cancer from coming back.
This trial tests giving a focused, higher dose of radiation to the lymph nodes above the collarbone after breast cancer treatment. It is for patients whose cancer did not fully disappear from those nodes after pre-surgery chemotherapy, to see if extra radiation can help prevent recurrence.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.